🧠Answer of the Week!
What did this large international survey study find regarding pain location in cluster headache?
✅ Most respondents had pain extending beyond the eye area
Read the full article: bit.ly/4xBeA3K#ClusterHeadache#Headache#HeadacheWeeklyQuestions
How can multidisciplinary care improve life for people w #headache? Dr. Brooke Reidy challenges the field to expand access, affordability, technology-enabled care, & treatment optimization for all
📽️: piped.video/Ub3OftCJ4nQ?si=pm0-…#InnovationChallenge
Can a #CGRP-targeting mAb reach the CNS?
#Fremanezumab was detected in #CSF within 1 day and persisted through day 30, with evidence of CGRP target engagement.
Could this contribute to #migraine prevention?
Read more: headachejournal.onlinelibrar…
What makes behavioral treatment work best for migraine and other headache disorders? This Innovation Challenge topic explores essential components, treatment dose, and which patient subgroups benefit most.
#HeadacheResearchPriorities#InnovationChallenge
What happens to #migraine treatment autoinjectors after the dose is given?
A call to action examines the growing environmental impact of single-use drug devices & proposes steps toward reuse, recycling & manufacturer accountability.
Read: headachejournal.onlinelibrar…
Spinal #CSFLeaks can be difficult to diagnose, especially when symptoms are atypical or brain imaging is negative.
This clinical review highlights the questions that can uncover important diagnostic clues.
Read more: headachejournal.onlinelibrar…
Identifying migraine biomarkers is critical to developing effective human migraine models. Explore our articles and "Collections": bit.ly/4haS37K
Has your research addressed this unanswered question? Submit to Headache!
#HeadacheResearchPriorities#InnovationChallenge
Meet the Innovation Challenge from the Headache journal: a 16-week series tackling unanswered questions from the 2024 AHS/NINDS Headache Research Priorities.
Learn more about the challenge → bit.ly/4iAPD4M
Follow the challenge at @HeadacheJournal
We are looking to fully define molecular signaling pathways responsible for headache episodes. Does your research hold the answer?
Learn more about Headache Innovation Challenge and submit your research
bit.ly/4yGUbv9#HeadacheResearchPriorities#InnovationChallenge
The Headache® RISE series returns this October!
Join this 2-part webinar series to build skills in scientific peer review and editorial leadership.
Attend both sessions to earn a certificate.
Register: bit.ly/4gWKCSS#PeerReview#ScientificEditing#AcademicPublishing
Which molecular targets drive headache initiation, and where do they act? Defining peripheral and central signaling pathways, including the roles of receptors and ion channels, could inform drug/therapeutic development.
#HeadacheResearchPriorities#InnovationChallenge
Options for acute #migraine treatment when CV risk limits #triptan use?
A meta-analysis found #lasmiditan improved 2-h #pain freedom, with no vasoconstrictive CV events detected across 5,126 trial participants.
Read more: headachejournal.onlinelibrar…